BioAge Labs, Inc. (BIOA) stock
BIOANasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.10−0.12 (-2.30%)
Close on Nov 17, 2026Market cap $234.07MP/E –Yield –
BioAge Labs operating margin
Operating margin is operating income as a percentage of revenue.
BioAge Labs's operating margin for the twelve months ending Jun 30, 2026 was -1026.3%. For fiscal 2025 it was -1031.5%.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -1031.5% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -1196.8% | −169.8 |
| Q1 FY2026 | Mar 31, 2026 | -915.4% | +218.0 |
| Q4 FY2025 | Dec 31, 2025 | -923.4% | – |
| Q3 FY2025 | Sep 30, 2025 | -1126.6% | – |
| Q2 FY2025 | Jun 30, 2025 | -1027.0% | – |
| Q1 FY2025 | Mar 31, 2025 | -1133.4% | – |
See a number that looks wrong?